other_material
confidence high
sentiment neutral
materiality 0.75
Indivior completes U.S. Domestication; begins trading on Nasdaq as Delaware corp under INDV
Indivior Pharmaceuticals, Inc.
- Scheme of Arrangement effective Jan 23, 2026; Indivior U.S. becomes ultimate parent of Indivior U.K.
- Common stock starts trading on Nasdaq Jan 26, 2026 under ticker INDV; CUSIP 45579U109.
- New 2026 Omnibus Equity Plan authorizes 17.5M shares; non-employee director annual cash retainer $75k-$100k.
- Directors and executive officers of Indivior U.K. continue in same roles at Indivior U.S.
- Note Purchase Agreement amended to reflect Indivior U.S. as reporting entity; indemnification agreements adopted.